Tech Company Financing Transactions
ZappRx Funding Round
CureDuchenne Ventures joined a funding round for ZappRx. The round closed on 10/18/2018.
Transaction Overview
Company Name
Announced On
10/18/2018
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
CureDuchenne Ventures (Debra Miller)
Proceeds Purpose
ZappRx and CureDuchenne's partnership will drive a more streamlined delivery of these life-changing drugs to Duchenne patients.
Company Information
Company Status
Acquired or Merged
Industry
Healthcare Services
Mailing Address
100 Franklin St.
Boston, MA 02110
USA
Boston, MA 02110
USA
Phone
Website
Email Address
Not Recorded
Overview
ZappRx is a prescription management system that allows healthcare providers, patients, and pharmacists to more easily interact and communicate. When a provider writes an e-prescription using ZappRx, the patient instantly receives the prescription on their smartphone and can easily fill, transfer, or renew it.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Zoe Barry
Chief Operating Officer
Sandy DiCesare
Vice President
Karen Tirozzi
VP - Bus. Development
Leslie Hoyt
VP - General Counsel
Jonathan Weinrieb
VP - Operations
Richard Kramer
VP - Product Management
Zeeshan Khan
Browse more venture capital transactions:
Prev: 10/18/2018: Crux Informatics venture capital transaction
Next: 10/18/2018: Oh My Green venture capital transaction
Share this article
About Database of VC Transactions
We record every notable VC transaction. VC investment data records reported here are derived from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs